Professor Wilbert S. Aronow

Professor of Medicine at New York Medical College Director of Cardiology Research at Westchester Medical Center

Biography

Wilbert S. Aronow MD is Professor of Medicine and Director of Cardiology Research at Westchester Medical Center and New York Medical College Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 21 books and is author or co-author of 1,718 papers,  212 book chapters in 116 books, 960 commentaries, 50 Letters to the Editor, and 1204 abstracts and is presenter or co-presenter of 1,582 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the ASPC, the AGS (Founding Fellow of Western Section), and the GSA. He has been a member of 185 editorial boards of medical journals, editor-in-chief of 5 journals, co-editor of 3 journals, deputy editor of 1 journal, executive editor of 2 journals, associate editor for 9 journals, and  guest editor for 7 other medical journals, and has reviewed manuscripts for 444  journals. He has received each year from 2001-2017 an outstanding teacher and researcher award from the medical residents and  from 2001-2022 from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College including the 2014 Chancellor’s Research Award and the 2021 excellence in Teaching Dean’s Faculty Award, the F1000 Faculty Member of the Year Award for the Faculty of Cardiovascular Disorders in 2011, and 2013-2021, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, a Distinguished Fellowship Award from the International Academy of Cardiology in July, 2012, and the Expertscape World Expert in Hypertension  Award in May, 2019.  He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure , co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and a coauthor of the 2017 ACC/AHA  guidelines for the management of patients with hypertension. He was a coauthor of a 2015 position paper from the International Lipid Expert Forum. He was a consultant to the American College of Physicians Information and Educational Resource (PIER) on the module of aortic stenosis, a consultant to the American Board of Internal Medicine on hypertension, a member of the Board of Directors of the ASPC, a member of the ACCP Cardiovascular Medicine and Surgery Network Steering Committee, and is a member of the Scientific Executive Committee of the International Academy of Cardiology. He has been a committee member of other professional societies and a consultant to many government agencies. He has mentored 304 cardiology fellows and 669 other trainees plus numerous junior faculty for publications listed on PubMed during his professional career.

 

Expert content

LBPMC Publications

RSS Aronow WS
  • Advances in Atrial Septal Defect Closure: Managing Pulmonary Hypertension and Expanding Treatment Criteria Applicability 2025-03-17
    Atrial septal defects (ASDs) are common congenital heart anomalies that can have significant long-term implications, particularly in the presence of pulmonary hypertension (PH). If left untreated, there is an increased risk of heart failure and Eisenmenger syndrome leading to a subsequent increase in patient morbidity and mortality. Advances in surgical and transcatheter closure techniques have […]
    Malkiel R Frager
  • Cardiac Complications of Radiation Therapy: A Narrative Review of Recent Literature 2025-03-06
    Radiation therapy is a widely used treatment for cancer, but it can have detrimental effects on the heart, leading to radiotherapy-induced cardiotoxicity. This condition has become an area of increasing concern, especially as cancer treatments continue to evolve. This review aims to explore the recent literature on radiotherapy-induced cardiotoxicity, focusing on the latest research published. […]
    Elisheva Eisenberg
  • Cardiac Manifestations in Children of Diabetic Mothers and Fathers 2025-03-03
    Diabetic individuals of reproductive age face higher risks of poor pregnancy outcomes and abnormal fetal development. Approximately 4.5% of women of reproductive age have diabetes, with non-Hispanic Black women having the highest prevalence of 15%. Research on the impact of paternal diabetes on offspring cardiac anomalies is limited, but it may interact with metabolic syndrome […]
    Ellen N Huhulea
  • Updated Review of Transcatheter Strategies and Intervention for Mitral Regurgitation 2025-02-27
    Mitral regurgitation (MR) is a prevalent valvular heart disease with significant morbidity, particularly in aging populations. Management strategies for MR have evolved from traditional open-heart surgery to innovative transcatheter approaches, addressing the limitations of surgical repair in high-risk patients. Transcatheter edge-to-edge repair, exemplified by devices such as MitraClip and PASCAL, has shown efficacy in reducing […]
    Siddhant Passey
  • Hypertensive Disorders of Pregnancy: A Review of the Current Literature and Future Directions 2025-02-27
    Hypertensive disorders in pregnancy (HDPs) are a leading cause of maternal and fetal morbidity and mortality worldwide. The pathophysiology is complex and still poorly understood but thought to involve a combination of maternal modifiable and nonmodifiable risk factors and placental changes with resultant end-organ dysfunction. Treatment of HDP involves a combination of lifestyle modification and […]
    Juhi Ramchandani
  • Navigating Pregnancy in Congenital Heart Disease: A Comprehensive Review of Maternal Outcomes 2025-02-25
    Congenital heart disease (CHD) affects approximately 0.5-1% of the population, with advancements in cardiovascular care enabling 97% of these individuals to survive to adulthood. Pregnancy in women with CHD presents with unique challenges due to increased hemodynamic demands and associated risks. This review provides a comprehensive analysis of maternal outcomes in women with CHD, focusing […]
    Rimsha Ahmad
  • A Review of Cardiac Preoperative Screening Guidelines for Liver Transplantation 2025-02-24
    Orthotopic liver transplant (OLT) medicine is a constantly evolving field, especially with the demographics of individuals with advanced liver disease drastically changing. OLT candidates are now older, and there is an increase of nonalcoholic steatohepatitis cirrhosis due to the epidemic of obesity, which has also resulted in an increase in cardiac comorbidities in this population. […]
    Jasmine Garg
  • Taurine and Berberine: Nutritional Interventions Targeting Cellular Mechanisms of Aging and Longevity 2025-02-19
    Aging is a multifaceted biological process characterized by progressive physiological decline and increased susceptibility to diseases. Central to this process are molecular and cellular changes that contribute to hallmark features of aging, including mitochondrial dysfunction, genomic instability, telomere attrition, and cellular senescence. Emerging research highlights the role of nutrient deficiencies in accelerating aging, bringing dietary […]
    Jatin Thukral
  • Sugar-Free but Not Risk-Free? Exploring Artificial Sweeteners and Cardiovascular Disease 2025-02-19
    The consumption of artificial sweeteners has significantly increased globally, particularly as a substitute for sugar for the management of conditions such as diabetes and obesity, which are significant risk factors for cardiovascular disease. Despite their widespread use, the health impacts of artificial sweeteners remain contentious. Research has suggested that certain sweeteners may contribute to systemic […]
    Lillian Huang
  • Predictive Accuracy of 24-Hour Ambulatory Blood Pressure Monitoring Versus Clinic Blood Pressure for Cardiovascular and All-Cause Mortality: A Systematic Review and Meta-Analysis 2025-02-14
    CONCLUSION: The findings of this study support the superiority of ABPM measurements in predicting both all-cause and cardiovascular mortality.
    Hamidreza Soleimani
  • Sickle Cell Trait and Vascular Health: Insights into Complications and Management 2025-02-11
    Sickle cell trait was once considered to benign hereditary condition, besides the association of renal medullary carcinoma, affecting red blood cells. The inherited disorder creates several health issues under various conditions, such as dehydration, hypoxia, or extreme physical exertion. Healthcare professionals and patients with the disorder should understand the importance of vascular complications in sickle […]
    Zeal Soni
  • Right Ventricular Myocardial Infarction: Pathophysiology, Diagnosis, and Therapeutic Approaches 2025-01-30
    Right ventricular myocardial infarction (RVMI) is a significant and distinct form of acute myocardial infarction associated with considerable morbidity and mortality. It occurs most commonly due to proximal right coronary artery obstruction, often in conjunction with inferior myocardial infarction. RVMI poses unique diagnostic and therapeutic challenges due to the anatomical and functional differences between the […]
    Manav Patel
  • A nuanced scrutiny of the segmental renal artery spectral Doppler in "Pickering" the right diagnosis 2025-01-23
    Approximately 5-10% of patients with hypertension have secondary hypertension. We describe a case of secondary hypertension from bilateral renal artery stenosis (RAS): "Pickering syndrome." This is a case of hypertension secondary to bilateral RAS which provides an opportunity to review secondary hypertension with a specific focus on RAS, in terms of when to consider work […]
    Adee Elhamdani
  • The Role of Intravenous Selexipag in Managing PAH and Bridging Gaps in Oral Treatment: A Narrative Review 2025-01-16
    Pulmonary arterial hypertension (PAH) is a rare and potentially fatal condition characterized by progressive increases in blood pressure in the arteries of the lungs. Oral selexipag, approved by the Food and Drug Administration (FDA) in 2015 for the treatment of PAH, targets prostacyclin receptors on pulmonary arterial vascular smooth muscle and endothelial cells to improve […]
    Sienna Goren
  • Intravascular Lithotripsy for Coronary Artery Calcification: An Expert Review 2025-01-15
    Coronary artery calcification is an impediment to percutaneous coronary interventions by obstructing the device pathway or stent deployment. To facilitate percutaneous coronary intervention in such complex lesions, high-pressure balloon dilations, atherectomy procedures, and specialty balloons are used but they all come with considerable limitations and periprocedural complications like dissection and perforation. To surpass these disadvantages, […]
    Ankit Agrawal
  • Sotatercept: A New Era in Pulmonary Arterial Hypertension 2025-01-08
    Pulmonary arterial hypertension (PAH) is a progressive disease characterized by proliferative remodeling and obliterative narrowing of the pulmonary vasculature. While outcomes have improved with existing treatments targeting 3 main pathways, there remains a critical need for novel therapies that address different and novel mechanisms of PAH. Sotatercept, recently Food and Drug Administration (FDA) approved, is […]
    Suneesh C Anand
  • Incidence, Mechanism, and Management of Atrial Ablation Procedure Complications: A Literature Review 2025-01-06
    The number of atrial catheter ablation procedures has significantly increased in recent years, becoming a first-line treatment modality for various supraventricular tachycardias due to their safety and efficacy. Complications, ranging from mild to life-threatening, can arise during different stages of the procedure, including vascular access complications (eg, hematoma or vascular fistula formation, retroperitoneal bleeding, etc.), […]
    Michael Nakhla
  • Optimizing Outcomes in Transcatheter Aortic Valve Replacement Addressing Cerebrovascular Complications and Enhancing Patient Safety 2025-01-06
    Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe aortic stenosis, becoming the gold standard for many patients. Despite its advantages over surgical aortic valve replacement, TAVR is associated with significant complications, including paravalvular leakage, conduction disorders, and cerebrovascular events. This review focuses on the pathophysiology, incidence, and management of cerebrovascular complications following […]
    Swati Chand
  • Curbside Consult Optimizing Statin Therapy in the Elderly: A Personalized Approach to Cardiovascular Disease Prevention 2025-01-03
    Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) play a vital role in managing and preventing cardiovascular disease, particularly in elderly populations who face elevated risks for atherosclerosis and related conditions. This review delves into the mechanisms of statin action, emphasizing their impact on low-density lipoprotein cholesterol levels, anti-inflammatory properties, and potential genetic factors influencing efficacy and […]
    Darshilkumar Maheta
  • Hypertension and Cognitive Disorders 2024-12-23
    Systemic hypertension is possibly the most important modifiable risk factor for the development of cognitive decline, both for mild cognitive impairment (MCI) and dementia. For effective blood pressure (BP) control, it requires proper assessment, using brachial, central, and ambulatory measurements, and monitoring with a focus on different BP parameters. Different BP parameters like pulse pressure, […]
    Kannayiram Alagiakrishnan